Skyhawk Therapeutics Announces Agreement with Genentech to Discover and Develop Small Molecule RNA S

Skyhawk will use its SkySTAR(TM )platform to develop drug candidates directed to multiple targets for oncology and neurodegenerative diseases. In exchange Skyhawk ... Lees verder

Bron:

ANP Pers support